NCT00506935View on ClinicalTrials.gov

Assessment of GVG for the Treatment of Methamphetamine Dependence

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

June 30, 2008

Conditions
Methamphetamine Addiction
Interventions
DRUG

GVG

5 grams GVG

DRUG

placebo

placebo

Trial Locations (1)

90024

UCLA, Los Angeles

All Listed Sponsors
collaborator

University of California, Los Angeles

OTHER

lead

Baylor College of Medicine

OTHER

NCT00506935 - Assessment of GVG for the Treatment of Methamphetamine Dependence | Biotech Hunter | Biotech Hunter